CellRight Technologies Launches Matrix OI Cortical Fibers

By Julie A. Vetalice

CellRight Technologies launched Matrix OI® Cortical Fibers, the latest in vivo verified osteoinductive matrix in its portfolio of regenerative human-derived osteobiologics.

Matrix OI Cortical Fibers are indicated for the treatment of surgically created or traumatic skeletal defects. The product, which comprises 100% human bone, is provided sterile in a range of volumes, is available freeze-dried and has a shelf life of five years. Hydrated Matrix OI Cortical Fibers may be delivered via syringe and open cannula.

CellRight verifies osteoinductivity for all product lots post-sterilization in an in vivo nude rat model. Matrix OI Cortical Fibers are also tested in vitro for the endogenous BMP-2 test marker for osteoinductivity. Other products in CellRight's portfolio include MatrixCellect® 100 Demineralized Bone Matrix Crunch and Putty, ConCelltrate™ 100 Demineralized Bone Matrix, etc.

Sources: CellRight Technologies, LLC; ORTHOWORLD Inc.

Product Labels: PRP/Cell-Based/Osteoinductive Materials

Tags: Product Launch